Rimbaut, Steven, Van Gutte, Céline, Van Brabander, Lina et al. · Acta clinica Belgica · 2016 · DOI
Quick Summary
This review examined research on ME/CFS published over 25 years and found that despite extensive scientific study, no single cause of the condition has been definitively proven. Currently, the best-supported treatments are cognitive behavioral therapy (a talk therapy) and graded exercise therapy (gradually increasing activity), though these show only moderate benefits. The study highlights how common ME/CFS is and how significantly it affects people's ability to work and participate in daily life.
Why It Matters
This comprehensive review underscores the complexity of ME/CFS and the absence of a definitive biomarker or single-cause explanation, validating patient experiences of diagnostic uncertainty. It identifies CBT and GET as the only moderately effective treatments available, which is important for patients and clinicians navigating treatment options while highlighting the urgent need for research into disease mechanisms.
Observed Findings
Prevalence rates of ME/CFS range from 0.2–6.4% globally, representing a substantial public health burden.
Employment rates among ME/CFS patients are low (27–41%), with productivity losses constituting the highest societal cost.
No proposed etiological factor has demonstrated strong, reproducible scientific evidence across studies.
Cognitive behavioral therapy and graded exercise therapy are the only treatments showing moderate effectiveness in the literature reviewed.
A biopsychosocial model integrating multiple hypotheses has gained favor over single-cause biomedical models.
Inferred Conclusions
The etiology of ME/CFS remains unknown despite decades of research, necessitating a shift from seeking a single causative mechanism to understanding multiple contributing factors.
Current evidence-based treatment options are limited to CBT and GET with only moderate efficacy, indicating a critical gap in disease-specific therapeutic options.
The substantial prevalence and employment impact of ME/CFS justify prioritization of research toward mechanistic understanding and improved treatments.
Remaining Questions
What are the primary etiological mechanisms underlying ME/CFS, and why has extensive research failed to identify reproducible biological markers?
What This Study Does Not Prove
This review does not establish the safety or appropriateness of graded exercise therapy for all ME/CFS patients, nor does it prove that psychological factors cause the condition—only that psychosocial interventions have moderate effectiveness. The absence of strong evidence for any etiological factor does not mean none exists; it reflects current scientific limitations and the heterogeneity of ME/CFS.
Why do CBT and GET show only moderate effectiveness, and are certain patient subgroups more responsive to these interventions?
What novel therapeutic approaches should be investigated given the inadequacy of current treatment options?
How does ME/CFS heterogeneity affect research interpretation, and are current diagnostic criteria capturing a single disease or multiple related conditions?